Optical coherence tomography (OCT) - versus angiography-guided strategy for percutaneous coronary intervention: a meta-analysis of randomized trials
Background Optical coherence tomography (OCT) guidance in percutaneous coronary intervention (PCI) has been shown to improve procedural outcomes. However, evidence supporting its superiority over angiography-guided PCI in terms of clinical outcomes is still emerging and limited. This study aimed to...
Uloženo v:
| Vydáno v: | BMC cardiovascular disorders Ročník 24; číslo 1; s. 262 - 10 |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Journal Article |
| Jazyk: | angličtina |
| Vydáno: |
London
BioMed Central
20.05.2024
BioMed Central Ltd Springer Nature B.V BMC |
| Témata: | |
| ISSN: | 1471-2261, 1471-2261 |
| On-line přístup: | Získat plný text |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
| Shrnutí: | Background
Optical coherence tomography (OCT) guidance in percutaneous coronary intervention (PCI) has been shown to improve procedural outcomes. However, evidence supporting its superiority over angiography-guided PCI in terms of clinical outcomes is still emerging and limited. This study aimed to compare the efficacy and safety of OCT-guided PCI versus angiography‐guided PCI in patients with coronary artery disease (CAD).
Methods
A systematic search of electronic databases was conducted to identify randomized control trials (RCTs) comparing the clinical outcomes of OCT-guided and angiography‐guided PCI in patients with CAD. Clinical endpoints including all-cause mortality, myocardial infarction (MI), target lesion revascularization (TLR), stent thrombosis and major adverse cardiac events (MACE) were assessed.
Results
Eleven RCTs, comprising 2,699 patients in the OCT-guided group and 2,968 patients in the angiography-guided group met inclusion criteria. OCT-guided PCI was associated with significantly lower rates of cardiovascular death(RR 0.56; 95%CI: 0.32–0.98;
p
= 0.04; I
2
= 0%), stent thrombosis(RR 0.56; 95%CI: 0.33–0.95;
p
= 0.03; I
2
= 0%), and MACE (RR 0.79; 95%CI: 0.66–0.95;
p
= 0.01; I
2
= 5%). The incidence of all-cause death (RR 0.71; 95%CI: 0.49–1.02;
p
= 0.06; I
2
= 0%), myocardial infarction (RR 0.86; 95%CI: 0.67–1.10;
p
= 0.22; I
2
= 0%) and TLR (RR 0.98; 95%CI: 0.73–1.33;
p
= 0.91; I
2
= 0%) was non-significantly lower in the OCT-guided group.
Conclusions
Among patients undergoing PCI, OCT-guided PCI was associated with lower incidences of cardiovascular death, stent thrombosis and MACE compared to angiography-guided PCI.
Trial registration
PROSPERO registration number: CRD42023484342. |
|---|---|
| Bibliografie: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Article-2 ObjectType-Feature-1 content type line 23 ObjectType-Undefined-3 |
| ISSN: | 1471-2261 1471-2261 |
| DOI: | 10.1186/s12872-024-03930-y |